Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document And Entity Information

v3.10.0.1
Document And Entity Information - CAD ($)
12 Months Ended
Nov. 30, 2018
Feb. 14, 2019
May 31, 2018
Document and Entity Information [Abstract]      
Entity Registrant Name Intellipharmaceutics International Inc.    
Trading Symbol ipci    
Document Type 20-F    
Current Fiscal Year End Date --11-30    
Entity Common Stock, Shares Outstanding   0  
Entity Public Float     $ 0
Amendment Flag false    
Entity Central Index Key 0001474835    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Well-known Seasoned Issuer No    
Document Period End Date Nov. 30, 2018    
Document Fiscal Year Focus 2018    
Document Fiscal Period Focus FY